Last 4,831 GBp
Change Today -37.00 / -0.76%
Volume 766.1K
SHP On Other Exchanges
SHP is not on other exchanges.
As of 10:23 AM 01/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Graham C. Hetherington

Former Director, Shire plc
AgeTotal Calculated CompensationThis person is connected to 12 board members in 1 different organizations across 4 different industries.

See Board Relationships
553,528,000 GBP
As of Fiscal Year 2013


Mr. Graham C. Hetherington served as the Chief Financial Officer of Shire Plc since July 1, 2008 until March 1, 2014 and served as its Principal Accounting Officer until March 1, 2014. Mr. Hetherington has experience of leading finance functions for consumer brand driven organizations within the food and drink industry. He served as Chief Financial Officer of Bacardi & Company Limited from July 2007 to December 31, 2007. Mr. Hetherington joined Bacardi from Allied Domecq ...

Read Full Background

Corporate Headquarters*

5 Riverwalk
Dublin, Co. Dublin 24


Phone: 353 1 429 7700
Fax: --

Board Members Memberships*

Former Chief Financial Officer, Group Finance Director, Director, Director -AD North America, Member of Executive Committee, Chief Financial Officer of ADSW Limited and Director of ADSW Limited
Former Director


There is no Education data available.

Other Affiliations*

Annual Compensation*

Salary480,000 GBP
Bonus425,000 GBP
Total Annual Compensation905,000 GBP

Stock Options*

Restricted Stock Awards2,475,000 GBP
All Other Compensation148,000 GBP
Unexercisable Options467
Unexercisable Options Value4,334 GBP
Total Value of Options4,333 GBP
Total Number of Options467

Total Compensation*

Total Annual Cash Compensation1,053,000 GBP
Total Short Term Compensation905,000 GBP
Other Long Term Compensation2,623,000 GBP
Total Calculated Compensation3,528,000 GBP
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SHP:LN 4,831.00 GBp -37.00


David E. I. Pyott Chairman and Chief Executive Officer
Allergan Inc.
Heather Bresch Chief Executive Officer, Director and Member of Science & Technology Committee
Mylan, Inc.
J. Michael Pearson Chairman and Chief Executive Officer
Valeant Pharmaceuticals International, Inc.
Yoshihiko Hatanaka Chief Executive Officer, President and Representative Director
Astellas Pharma, Inc.
Paul R. Perreault BA PsychologyChief Executive Officer, Managing Director, Executive Director and Member of Innovation & Development Committee
CSL Ltd.
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SHIRE PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at